Decreased baroreflex sensitivity (BRS) is a prognostic marker in essential hypertension. Animal experiments suggest that decreased BRS is related to increased oxidative stress. Our study was aimed at testing whether oxidative stress, estimated by isoprostane 15-F 2t -IsoP urinary levels, is correlated to BRS variation in healthy subjects as well as in patients suffering from essential hypertension. Urinary 15-F 2t -IsoP levels and BRS were evaluated in two groups of subjects: healthy volunteers (n ¼ 64) and patients with untreated mild-to-moderate hypertension (n ¼ 33). Data were analysed in 61 and 31 subjects, respectively, BRS analysis being impossible in three and two subjects, respectively. 15-F 2t -IsoP levels were measured using gas chromatography/mass spectrometry. BRS was measured using the sequence method [PS þ /RR þ and PSÀ/RRÀ] and crossspectral analysis (CSP) (MF gain) at rest, lying down. No significant correlation was found between basal urinary 15-F 2t -IsoP levels and BRS (sequence method and CSP) in either healthy controls or hypertensive patients. Our study shows that oxidative stress is not involved in interindividual variations of BRS in healthy subjects and patients suffering from mild-to-moderate hypertension
Introduction
Baroreflex sensitivity (BRS) is used as an indicator of cardiac autonomic regulation and is very useful in cardiovascular prognosis. Alteration of cardiovascular autonomic regulation plays an important part in generating hypertension.
1,2 After a myocardial infarction, a fall in BRS 3 or variability in heart rate (HR), 4 or increased blood pressure (BP) variability 5, 6 are linked to a higher cardiovascular morbidity rate. 7 In subjects considered to be healthy, BRS varies greatly from one person to another. The physiological parameters found to be responsible for interindividual variations in BRS are age, HR, systolic and diastolic BP, body weight, smoking and sex. However, all these parameters together are thought to be responsible for only about 50% of interindividual differences in BR 8, 9 and other mechanisms must be sought. 10 Oxidative stress alters BRS in animal models: exposure of atherosclerotic sinuses of rabbits to free radical scavengers (superoxide dismutase and catalase) increased baroreceptor activity; conversely, free radical generation by the chemical reaction of xanthine and xanthine oxidase suppressed baroreceptor activity in a normal carotid sinus. 11 Conversely, antioxidant treatment with alpha-lipoic acid 12 or vitamin E 13 for four months improved autonomic neuropathy and HR variability in NIDDM patients. However, there is no clear evidence that BRS is correlated to oxidative stress in healthy subjects and hypertensive patients.
Isoprostanes are chemically stable lipid peroxidation products of arachidonic acid, the quantification of which provides a novel approach to the assessment of oxidative stress in vivo.
14 Of these isoprostanes, 15-F 2t -IsoP is a stable, sensitive and specific product of lipid peroxidation, currently quantified in urines and plasma as a lipid peroxidation biomarker. 15 The purpose of this study was to determine whether oxidative stress, estimated by 15-F 2t -IsoP urinary (IPU) levels, is correlated to BRS variations in healthy subjects as well as in patients with essential hypertension.
Methods

Patients
In all, 64 white healthy normotensive subjects (systolic BP (SBP) below 140 mmHg and diastolic BP (DBP) below 90 mmHg according to office readings) were recruited successively during routine occupational health consultations at Grenoble University Hospital.
In all, 33 white patients referred to the 'Service de Cardiologie et Hypertension Artérielle' (Cardiology and Hypertension Department) at Grenoble University Hospital were included in the study between January 2000 and June 2002. Inclusion criteria were: untreated (never treated) mild-to-moderate essential hypertension, clinically diagnosed according to WHO criteria (SBP: 140-159 mmHg and/or DBP: 90-99 mmHg on three consecutive occasions). Exclusion criteria were: secondary hypertension, coronary heart disease and potential confounding factors associated with increased F 2 -isoprostane production (current cigarette smoking, 16 hypercholesterolemia 17 and diabetes 18 ). Secondary hypertension was excluded by means of clinical and biochemical assessment. Coronary heart disease was excluded on the basis of clinical history, ECG and echocardiography. In total, 25 patients included in the present study simultaneously participated in a previous study aimed at comparing lipid peroxidation levels in patients with hypertension and healthy subjects, the results of which were published. 19 
Study design
Both patients and controls underwent the investigations in a single day. BP measurement (JNC VII), echocardiography, total, HDL and LDL plasma cholesterol, triglyceride and glucose quantification were performed using a methodology previously described.
20,21
Assessing baroreflex sensitivity After a preliminary 10-min rest period, BP was measured continuously for 20 min lying down. 22 All BP measurements were noninvasive, using a finger plethysmograph (Finapres 2300tm, Ohmeda BOC Inc., USA 23 ). The continuous analog BP recording was sampled at 200 Hz and digitalized at 12 bits by a PC (486DX2/33 model, Advantech PCLabcard 718, IBM Corporation, Lexington, MA, USA). From these readings, for every cardiac cycle, the software calculated SBP, DBP and HR (ISN-UJF, CNRS, France). 24 BRS evaluation was based on analysing simultaneous fluctuations in both BP and HR using two widely accepted techniques, namely the sequence method and cross-spectral analysis (CSP).
The sequence method 25 analyses at least three cardiac cycles in which both SBP and pulse intervals are either steadily increasing (PS þ / RR þ sequences) or decreasing (PSÀ/RRÀ sequences). The variation threshold was fixed at 1 mmHg for the SBP and 4 ms for the pulse interval. Only those sequences for which changes in the two parameters had a correlation coefficient of X0.95 were analysed. The slope of the linear regression for changes in BP and pulse interval gives the BRS: the mean of the various slopes calculated for a single subject was used as the definitive BRS value. CSP has been previously described by Robbe et al 26 and De Boer et al 27 . The spectral characteristics of the stationary segments of the whole recording were calculated by a direct fast-Fourier transform algorithm. The modulus of the transfer function between SBP and pulse interval was examined in a midfrequency band (66-127 MHz) and considered to be a BRS index when the coefficient of coherence 40.5.
28
Urinary 15-F 2t -IsoP measurements
Urine samples (20 ml) were collected between 0800 and 1000 in polyethylene tubes, immediately refrigerated and transferred to the laboratory, aliquoted and stored at À201C. IPU were measured using gas chromatography-mass spectrometry as previously described. 29 The results were corrected to urinary levels of creatinine. Final results were expressed as pmol per mmol of creatinine. Observers were blinded to the source of samples for technical analysis.
Statistical analysis
Sample size calculations of the population were based on the main objective to detect a coefficient of correlation of at least 0.30 (10% of the variance) between IPU and the BRS with a ¼ 0.05 and a power (1Àb) ¼ 0.90.
Statistical analyses were performed using SPSS software (SPSS Inc, Chicago, IL, USA). When distribution normality was verified, data were expressed as mean7s.d. Comparisons were made using Student's t-test or ANOVA. The relationship between continuous variables was evaluated using the Pearson correlation coefficient. Values of Po0.05 were considered significant.
Results
Subject characteristics
Three healthy subjects and two hypertensives were excluded from the study because it was impossible Oxidative stress and baroreflex sensitivity O Ormezzano et al to analyse their BRS (atrial premature beat or poor quality of recordings). The demographic, clinical and baseline cardiovascular data of the remaining 61 hypertensive patients and 31 controls are listed in Table 1 . Univariate analysis of correlations between BRS and clinical parameters is given in Table 2 . In multivariate analysis, the BRS evaluated by CSP is correlated with age, by sequential analysis (PS þ / RR þ et PSÀ/RRÀ), BR being correlated with age and HR.
BRS and urinary 15-F 2t -IsoP
BRS measured using a sequential method or by CSP is not correlated to the quantity of IPU, for either all the subjects and for the groups of healthy or hypertensive subjects (Table 3) .
Nor is there any difference in the quantity of IPU between patients with the highest and lowest BRS (Figure 1) . The results remain negative when age, gender, BMI or BP are taken into account.
Discussion
Our study shows that lipid peroxidation is not correlated to BRS in either healthy and mild-tomoderate hypertensive subjects.
Reduced BRS is an early event in essential hypertension. It appears that there is increased sympathetic and reduced vagal cardiac drive coupled with enhanced vasomotor sympathetic modulation. 30 A tight link between increasing arterial pressure and the continuum of changes in autonomic markers has been shown, including patients with BP in the upper normal range. Free radical generation has been hypothesized as being involved in reduced BRS in essential hypertension. However, these data came from animal models of hypertension, 31 and no clear data indicated that this would be the case in humans.
BRS was analysed using a noninvasive, nonpharmacological method, consisting of studying, using a sequential or spectral method, the spontaneous variations in the RR interval and BP measured by Finapres. This method was used widely in many studies to assess the BRS. [32] [33] [34] Both sequence methods and CSP further showed that BRS was decreased in patients with mild-tomoderate hypertension. 35 In our study, BRS in sequential analysis was found, as in the literature, 36, 37 to depend on age, gender, DBP, SBP and HR.
Isoprostanes are currently the most sensitive and specific biomarkers of lipid peroxidation in vivo. 38 Precautions were taken to avoid potential confounding bias in isoprostane measurement. 15 Patients with previously diagnosed diabetes, hypercholesteromia, and smokers were excluded. Similarly, to avoid treatment bias, only patients who had never been treated were included. Exclusion of other cardiovascular diseases was based on clinical history, electrocardiogram and echocardiography.
After excluding potential risk of bias, no relation was found between BRS and lipid peroxidation levels in healthy and hypertensive subjects. This study does not lack the power to detect a correlation between IPU and BRS because the number of subjects (92 in the total population) was based on the main objective to detect a contribution of at least 10% of the IPU of the overall variability of BRS with a ¼ 0.05 and a power of 90%.
Although this study does not rule out the possibility that lipid peroxidation contributes to the overall variability of the BRS in later stages of essential hypertension, it shows that it does not contribute to the overall variability of the BRS in healthy subjects and in the early stages of the hypertension associated with a BRS decrease. This strongly suggests that oxidative stress in not involved in BRS.
Prospects
In conclusion, our study shows that oxidative stress is not involved in interindividual variations of BRS in healthy subjects or patients with mild-to-moderate hypertension. The global population studied was divided into quartiles (Q1 to Q4) according to BRS values measured using the crossspectral or sequential method. PS þ /RR þ and PSÀ/RRÀ: BRS measurements according to sequences of three or more successive beats in which SBP and pulse interval increased or decreased. CSP: crossspectral analysis in mild-frequency band (see text for explanation).
